EconomyBetter economy, merger boom boosts US bank earnings

Better economy, merger boom boosts US bank earnings

-

New York, United States: Profits at Goldman Sachs leaped on a merger boom, while JPMorgan Chase’s results were boosted by the halo effect on loan quality from an improving macro economy, according to results released Tuesday.

The two financial heavyweights both reported soaring second-quarter profits compared with the year-ago period when large banks set aside massive provisions in case clients defaulted amid the coronavirus downturn.

But vaccines for Covid-19 and the gradual reopening of the economy have made those days seem long ago.

“Consumer and wholesale balance sheets remain exceptionally strong as the economic outlook continues to improve,” said Chief Executive Jamie Dimon.

The biggest US bank by assets, JPMorgan kicked off the earnings season for the sector, reporting that profits more than doubled to $11.9 billion, including a boost from $3 billion that had been set aside as reserves.

JPMorgan had budgeted $8.9 billion for bad loans in the year-ago period, but it reported just $734 million in charge-offs for bad loans in the second quarter.

But revenues for the period fell eight percent to $30.5 billion, as the bank’s trading business saw much less activity compared with the year-ago level.

At Goldman, profits came in at $5.3 billion in the second quarter, up from just $197 million in the year-ago period.

Revenues were $15.4 billion, up 16 percent from the year-ago period and the second-highest quarterly revenues in the firm’s history after the first quarter of 2021.

“Our second quarter performance and record revenues for the first half of the year demonstrate the strength of our client franchise and our continued progress on our strategic priorities,” said Chief Executive David Solomon, who said the firm would work to support clients who “still face challenges in overcoming the pandemic.”

Goldman’s results reflected a jump in financial advisory revenues due to a rise in completed mergers and acquisition transactions. The firm’s backlog of additional deals also “increased significantly compared with the end of 2020,” Goldman said.

However, Goldman also saw a steep drop in markets revenue on lower volatility compared with the 2020 period.

But as with JPMorgan, Goldman’s results were lifted by reserve releases and a favorable comparison from the year-ago period when Goldman also established hefty provisions for bad loans.

Last year’s results were also dented by legal and regulatory costs that were more than 10 times the sum in the 2021 period.

Besides announcing results, Goldman announced a boost in its quarterly dividend to $2 per share from the prior $1.25.

Shares of JPMorgan edged up 0.1 percent to $158.20 while Goldman rose 1.5 percent to $386.10 in pre-market trading.

AFP
AFP is a leading global news agency for comprehensive, verified coverage of events shaping the world.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Two Koreas restore severed communications in surprise thaw

Seoul, South Korea: North and South Korea signaled a surprise thaw in relations on Tuesday, announcing the restoration of...

Hong Kong court to give first national security trial verdict

Hong Kong, China: A Hong Kong court will lay down a marker on the city's future legal landscape Tuesday...

Sacrifice, exile: how Filipina Hidilyn Diaz made Olympic history

Tokyo, Japan: Triumphant weightlifter Hidilyn Diaz will now forget the years of exile, sacrifice, training, and nutrition that took...

World Bank to finance extra Covid jabs for poorer nations

Geneva, Switzerland: A new World Bank financing mechanism will allow developing countries to purchase Covid-19 vaccines collectively through the...

Record-shattering heatwaves caused by pace of warming: study

Paris, France: Heatwaves that obliterate temperature records as in western Canada last month and Siberia last year are caused...

After Covid jab, BioNTech sets sights on malaria vaccine

Frankfurt, Germany: Germany's BioNTech, which developed a coronavirus vaccine with US giant Pfizer in record time, said Monday it...

Must read

You might also likeRELATED
Recommended to you